Untreated Essential Thrombocythemia Evolving to Biphenotypic Leukemia, Philadelphia Chromosome Positive With Monosomy 7: Response to Imatinib and Reduced-Intensity Allogeneic Stem Cell Transplant

Leukemia- United Kingdom

doi 10.1038/sj.leu.2403725

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Multiple Myeloma With Concomitant JAK2-positive Essential Thrombocythemia Post-Successful Autologous Peripheral Blood Hematopoietic Stem Cell Transplant

Bone Marrow Transplantation
TransplantationHematology
2010English

Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Preliminary Results of the Safety of Immunotherapy With Gemtuzumab Ozogamicin Following Reduced Intensity Allogeneic Stem Cell Transplant in Children With CD33+ Acute Myeloid Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2005English

Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients

Hematology Reports
Hematology
2012English

Donor-Derived Philadelphia Chromosome Positive B-Cell Lymphoblastic Leukemia Presenting With Renal Allograft Involvement in the First Year Post-Transplant

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Complete Remission From Chronic Myelogenous Leukemia-Blastic Crisis Caused by Reduced Intensity Stem Cell Transplantation Following Partial Remission Due to Imatinib

Internal Medicine
Internal MedicineMedicine
2004English

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

Cancer Control
MedicineOncologyHematology
2011English

No Evidence of Impact of Maraviroc on Outcome After Allogeneic Hematopoietic Stem Cell Transplant With Reduced Intensity Conditioning (RIC)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy